Page 7 - Sheppard Mullin Capabilities Overview Prepared for Regeneron

Team Services
Corporate
• Formation and organization
• Joint ventures and strategic alliances
• Mergers and acquisitions
• Manufacturing, supply and distribution agreements • Research, collaboration and clinical trial agreements • Securities law compliance
• Proxy contests
Finance and Capital Markets
• Corporate finance representing issuers, private equity funds and venture capital firms
• Initial public offerings and follow-on offerings
• Private placements of debt and equity
• Structuring debt and equity investments, including secured investments
• Monetizing royalties from intellectual property licenses
Intellectual Property
• Patent prosecution and counseling, including complex global partner portfolio procurement and management
• Due diligence and opinions for IP portfolios
• Patent infringement analysis
• Licensing, technology and other complex transactions and agreements
• Protection of trademark, trade secrets and other business assets
Regulatory and Compliance
• Premarket strategies, including FDA and EU product approval, lifecycle manage- ment and exclusivity
• Post-market enforcement, manufacturing (cGMP), labeling and promotion
• Healthcare compliance – fraud and abuse, pricing and reimbursement issues
• Data privacy and cybersecurity, including HIPAA
• Digital health, telemedicine and novel medical devices
Litigation
• Complex commercial – trial and appellate including trademark, trade secret, anti- trust and unfair competition matters
• Hatch-Waxman litigation, patents and other intellectual property
• Products liability
• Medicare investigation defense and litigation
• False Claims Act litigation and defense
Antitrust and Competition
• Antitrust strategy and defense - mergers and acquisitions, joint ventures, intellec- tual property licenses, alliances and conduct matters
• Federal Trade Commission and U.S. Department of Justice investigations
• Federal Trade Commission MMA pharmaceutical agreement compliance
• Global transactions, Committee on Foreign Direct Investment in the U.S. (CFIUS)
and Ex-U.S. merger control and Foreign Direct Investment control
• Hart-Scott-Rodino Act compliance
• Import/export controls, sanctions and customs issues
Bankruptcy and Creditors’ Rights
Real Estate
• Acquisition and leasing
• Land use and regulation
• Infrastructure and facilities financing
Tax and Employee Benefits
Representative Clients
Life Sciences Industry Team
-7 -